BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu W, Wang Y, Wang Y, Lv S, Xu X, Dong X. Screening of differentially expressed genes and identification of NUF2 as a prognostic marker in breast cancer. Int J Mol Med 2019;44:390-404. [PMID: 31198978 DOI: 10.3892/ijmm.2019.4239] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Cai C, Zeng Q, Zhou G, Mu X. Identification of novel transcription factor-microRNA-mRNA co-regulatory networks in pulmonary large-cell neuroendocrine carcinoma. Ann Transl Med 2021;9:133. [PMID: 33569435 DOI: 10.21037/atm-20-7759] [Reference Citation Analysis]
2 Jiang X, Jiang Y, Luo S, Sekar K, Koh CKT, Deivasigamani A, Dong Q, Zhang N, Li S, Hao F, Goh BKP, Ooi LL, Wang Y, Hui KM. Correlation of NUF2 Over-expression with Poorer Patient Survival in Multiple Cancers. Cancer Res Treat. 2021;. [PMID: 33421974 DOI: 10.4143/crt.2020.466] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu Y, Teng L, Fu S, Wang G, Li Z, Ding C, Wang H, Bi L. Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers. BMC Cancer 2021;21:644. [PMID: 34053447 DOI: 10.1186/s12885-021-08318-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu L, Qu J, Dai Y, Qi T, Teng X, Li G, Qu Q. An interactive nomogram based on clinical and molecular signatures to predict prognosis in multiple myeloma patients. Aging (Albany NY) 2021;13:18442-63. [PMID: 34260414 DOI: 10.18632/aging.203294] [Reference Citation Analysis]
5 Chen M, Li S, Liang Y, Zhang Y, Luo D, Wang W. Integrative Multi-Omics Analysis of Identified NUF2 as a Candidate Oncogene Correlates With Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer. Front Oncol 2021;11:656509. [PMID: 34178642 DOI: 10.3389/fonc.2021.656509] [Reference Citation Analysis]
6 Vasiliou SK, Filippou PS, Clotet-Freixas S, Soosaipillai A, Batruch I, Viktor Tsianos F, Konvalinka A, Diamandis EP. Transcriptome profiling and proteomic validation reveals targets of the androgen receptor signaling in the BT-474 breast cancer cell line. Clin Proteomics 2022;19:14. [PMID: 35568821 DOI: 10.1186/s12014-022-09352-2] [Reference Citation Analysis]
7 Wang W, He Y, Zhao Q, Zhao X, Li Z. Identification of potential key genes in gastric cancer using bioinformatics analysis. Biomed Rep. 2020;12:178-192. [PMID: 32190306 DOI: 10.3892/br.2020.1281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Subramonian D, Chen TA, Paolini N, Zhang XD. Poly-SUMO-2/3 chain modification of Nuf2 facilitates CENP-E kinetochore localization and chromosome congression during mitosis. Cell Cycle 2021;20:855-73. [PMID: 33910471 DOI: 10.1080/15384101.2021.1907509] [Reference Citation Analysis]
9 Zhai X, Yang Z, Liu X, Dong Z, Zhou D. Identification of NUF2 and FAM83D as potential biomarkers in triple-negative breast cancer. PeerJ 2020;8:e9975. [PMID: 33005492 DOI: 10.7717/peerj.9975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Qi A, Ju M, Liu Y, Bi J, Wei Q, He M, Wei M, Zhao L. Development of a Novel Prognostic Signature Based on Antigen Processing and Presentation in Patients with Breast Cancer. Pathol Oncol Res 2021;27:600727. [PMID: 34257557 DOI: 10.3389/pore.2021.600727] [Reference Citation Analysis]